What's new
Dear Stockholders
We are sure that Immuno-Biological Laboratories Co., Ltd. has been contributing to human health by supplying various research reagents and clinical reagents for cancer research as well as research reagents for inflammatory cytokines, growth factors, and antibodies for use against those proteins. Continuously we keep working on the development of immuno-diagnosis for intractable diseases based on the accumulated technical know-how acquired through the experiences of antibody production. In addition to the existing business, we create transgenic animals and analyze genes and proteins from such animals seeking new targets for drug discovery. Having antibody-production technologies as our core technologies, we will continue to supply products which meet the needs of the growing life science community and increase our corporate value.


